Clinical Research Directory
Browse clinical research sites, groups, and studies.
An Imaging Technology, Contrast-Enhanced Mammography, in Predicting Breast Cancer
Sponsor: M.D. Anderson Cancer Center
Summary
This clinical trial examines a new imaging technology, contrast-enhanced mammography, in predicting breast cancer. Contrast-enhanced mammography is similar to standard mammography, but it includes an intravenous (by vein) injection of iodine-based contrast, which makes tissue and blood vessels more visible in scans. Contrast-enhanced mammography may work better in detecting cancer in the breast that is not seen on other imaging tests and may help doctors find the most suspicious areas of the breast to biopsy, which could increase the chances of finding breast cancer.
Official title: Contrast-Enhanced Mammography (CEM) for the Evaluation and Targeted Biopsy of Suspicious Mammographic Architectural Distortions
Key Details
Gender
All
Age Range
25 Years - 85 Years
Study Type
INTERVENTIONAL
Enrollment
100
Start Date
2021-04-08
Completion Date
2028-03-01
Last Updated
2026-03-27
Healthy Volunteers
No
Conditions
Interventions
Biopsy
Undergo biopsy
Contrast-Enhanced Mammography
Undergo CEM
Questionnaire Administration
Ancillary studies
Radioactive Iodine
Given IV
Locations (1)
M D Anderson Cancer Center
Houston, Texas, United States